Misclassification bias in estimating clinical severity of SARS-CoV-2 variants.
作者信息
Yek Christina, Warner Sarah, Mancera Alex, Kadri Sameer S
机构信息
Critical Care Medicine Department, NIH Clinical Center, Bethesda, MD 20892, USA.
Critical Care Medicine Department, NIH Clinical Center, Bethesda, MD 20892, USA.
出版信息
Lancet. 2022 Sep 10;400(10355):809. doi: 10.1016/S0140-6736(22)01469-6.
Abstract
摘要
相似文献
1
Misclassification bias in estimating clinical severity of SARS-CoV-2 variants.估计新冠病毒变异株临床严重程度时的错误分类偏倚。
Lancet. 2022 Sep 10;400(10355):809. doi: 10.1016/S0140-6736(22)01469-6.
2
Misclassification bias in estimating clinical severity of SARS-CoV-2 variants - Authors' reply.关于评估新冠病毒变异株临床严重程度时的错误分类偏倚——作者回复
Lancet. 2022 Sep 10;400(10355):809-810. doi: 10.1016/S0140-6736(22)01432-5.
3
Molecular Determinants of SARS-CoV-2 Variants.严重急性呼吸综合征冠状病毒2变种的分子决定因素
Trends Microbiol. 2021 Oct;29(10):871-873. doi: 10.1016/j.tim.2021.07.002. Epub 2021 Jul 27.
4
Prediction of putative potential siRNAs for inhibiting SARS-CoV-2 strains, including variants of concern and interest.预测针对 SARS-CoV-2 株（包括关注和感兴趣的变体）的潜在有效 siRNA。
Future Microbiol. 2022 Apr;17:449-463. doi: 10.2217/fmb-2021-0130. Epub 2022 Mar 14.
5
6
Subgenomic RNAs and Their Encoded Proteins Contribute to the Rapid Duplication of SARS-CoV-2 and COVID-19 Progression.亚基因组 RNA 及其编码蛋白有助于 SARS-CoV-2 的快速复制和 COVID-19 的进展。
Biomolecules. 2022 Nov 12;12(11):1680. doi: 10.3390/biom12111680.
7
Emerging SARS-CoV-2 variants can potentially break set epidemiological barriers in COVID-19.新出现的 SARS-CoV-2 变异株可能会打破 COVID-19 中既定的流行病学屏障。
J Med Virol. 2022 Apr;94(4):1300-1314. doi: 10.1002/jmv.27467. Epub 2021 Nov 29.
8
Targeting ACLY efficiently inhibits SARS-CoV-2 replication.靶向 ACLY 能有效抑制 SARS-CoV-2 复制。
Int J Biol Sci. 2022 Jul 11;18(12):4714-4730. doi: 10.7150/ijbs.72709. eCollection 2022.
9
Do chronic infections breed dangerous new variants?慢性感染会滋生危险的新变种吗？
Science. 2021 Aug 20;373(6557):848. doi: 10.1126/science.373.6557.848.
10
Suppression of SARS-CoV-2 Replication with Stabilized and Click-Chemistry Modified siRNAs.用稳定的和点击化学修饰的 siRNAs 抑制 SARS-CoV-2 的复制。
Angew Chem Int Ed Engl. 2022 Sep 19;61(38):e202204556. doi: 10.1002/anie.202204556. Epub 2022 Aug 12.
引用本文的文献
1
Generalizing the Use of a Procalcitonin-Guided Antibiotic Algorithm to a New Era of SARS-CoV-2 Infection.将降钙素原指导的抗生素治疗方案应用推广至新型冠状病毒肺炎感染的新时代。
Chest. 2024 Mar;165(3):e85-e86. doi: 10.1016/j.chest.2023.10.041.
2
COVID-19 Vaccination Effectiveness in the General Population of an Italian Province: Two Years of Follow-Up.意大利某省普通人群中新冠疫苗接种的有效性：两年随访
Vaccines (Basel). 2023 Aug 4;11(8):1325. doi: 10.3390/vaccines11081325.
本文引用的文献
1
Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.比较分析英国住院和死亡风险与 SARS-CoV-2 奥密克戎（B.1.1.529）和德尔塔（B.1.617.2）变异株的关系：一项队列研究。
Lancet. 2022 Apr 2;399(10332):1303-1312. doi: 10.1016/S0140-6736(22)00462-7. Epub 2022 Mar 16.
2
Risk Factors for Severe COVID-19 Outcomes Among Persons Aged ≥18 Years Who Completed a Primary COVID-19 Vaccination Series - 465 Health Care Facilities, United States, December 2020-October 2021.≥18 岁完成初级 COVID-19 疫苗接种系列的人群中严重 COVID-19 结局的危险因素-465 家医疗保健机构，美国，2020 年 12 月-2021 年 10 月。
MMWR Morb Mortal Wkly Rep. 2022 Jan 7;71(1):19-25. doi: 10.15585/mmwr.mm7101a4.
3
Risk Factors for Severe COVID-19 in Children.儿童重症 COVID-19 的危险因素。
Pediatrics. 2022 Jan 1;149(1). doi: 10.1542/peds.2021-053418. Epub 2021 Dec 22.
4
Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis.无症状 SARS-CoV-2 感染：系统评价和荟萃分析。
Proc Natl Acad Sci U S A. 2021 Aug 24;118(34). doi: 10.1073/pnas.2109229118.
Zotero 插件